Part I : The Business Culture of Science Since 2000, there has been a 20-fold increase* in research funding for anti-aging medicine. Wow! That’s a good thing. But let’s keep our eyes on the ball. There is danger that this welcome infusion of capital may be biasing research priorities toward those that are most likely […]
